These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38450758)

  • 21. Relaxin-induced changes in renal function and RXFP1 receptor expression in the female rat.
    Bogzil AH; Ashton N
    Ann N Y Acad Sci; 2009 Apr; 1160():313-6. PubMed ID: 19416210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial.
    Snowdon VK; Lachlan NJ; Hoy AM; Hadoke PW; Semple SI; Patel D; Mungall W; Kendall TJ; Thomson A; Lennen RJ; Jansen MA; Moran CM; Pellicoro A; Ramachandran P; Shaw I; Aucott RL; Severin T; Saini R; Pak J; Yates D; Dongre N; Duffield JS; Webb DJ; Iredale JP; Hayes PC; Fallowfield JA
    PLoS Med; 2017 Feb; 14(2):e1002248. PubMed ID: 28245243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of relaxin-3 and a selective relaxin-3 receptor agonist on food and water intake and hypothalamic neuronal activity in rats.
    de Ávila C; Chometton S; Lenglos C; Calvez J; Gundlach AL; Timofeeva E
    Behav Brain Res; 2018 Jan; 336():135-144. PubMed ID: 28864207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and optimization of small-molecule agonists of the human relaxin hormone receptor RXFP1.
    Xiao J; Huang Z; Chen CZ; Agoulnik IU; Southall N; Hu X; Jones RE; Ferrer M; Zheng W; Agoulnik AI; Marugan JJ
    Nat Commun; 2013; 4():1953. PubMed ID: 23764525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relaxin family peptide receptors Rxfp1 and Rxfp2: mapping of the mRNA and protein distribution in the reproductive tract of the male rat.
    Filonzi M; Cardoso LC; Pimenta MT; Queiróz DB; Avellar MC; Porto CS; Lazari MF
    Reprod Biol Endocrinol; 2007 Jul; 5():29. PubMed ID: 17623071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of small-molecule agonists of human relaxin family receptor 1 (RXFP1) by using a homogenous cell-based cAMP assay.
    Chen CZ; Southall N; Xiao J; Marugan JJ; Ferrer M; Hu X; Jones RE; Feng S; Agoulnik IU; Zheng W; Agoulnik AI
    J Biomol Screen; 2013 Jul; 18(6):670-7. PubMed ID: 23212924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure.
    Granberg KL; Sakamaki S; Larsson N; Bergström F; Fuchigami R; Niwa Y; Ryberg E; Backmark A; Kato H; Miyazaki S; Iguchi K; Sakamoto T; Persson M; Idei A; Prieto Garcia L; Villar IC; Gradén H; Bergonzini G; Arvidsson T; Fujita T; Althage M; Ulander J; Kimura J; Yoneda H; Fjellström O; Mochida H; Lal M
    J Med Chem; 2024 Mar; 67(6):4419-4441. PubMed ID: 38502782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relaxin peptide hormones are protective during the early stages of ischemic stroke in male rats.
    Bergeron LH; Willcox JM; Alibhai FJ; Connell BJ; Saleh TM; Wilson BC; Summerlee AJ
    Endocrinology; 2015 Feb; 156(2):638-46. PubMed ID: 25456068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ligand-activated RXFP1 gene therapy ameliorates pressure overload-induced cardiac dysfunction.
    Sasipong N; Schlegel P; Wingert J; Lederer C; Meinhardt E; Ziefer A; Schmidt C; Rapti K; Thöni C; Frey N; Most P; Katus HA; Raake PWJ
    Mol Ther; 2021 Aug; 29(8):2499-2513. PubMed ID: 33839322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The different ligand-binding modes of relaxin family peptide receptors RXFP1 and RXFP2.
    Scott DJ; Rosengren KJ; Bathgate RA
    Mol Endocrinol; 2012 Nov; 26(11):1896-906. PubMed ID: 22973049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.
    Halls ML; van der Westhuizen ET; Bathgate RA; Summers RJ
    Br J Pharmacol; 2007 Mar; 150(6):677-91. PubMed ID: 17293890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a selective agonist for relaxin family peptide receptor 3.
    Wei D; Hu MJ; Shao XX; Wang JH; Nie WH; Liu YL; Xu ZG; Guo ZY
    Sci Rep; 2017 Jun; 7(1):3230. PubMed ID: 28607363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged RXFP1 and RXFP2 signaling can be explained by poor internalization and a lack of beta-arrestin recruitment.
    Callander GE; Thomas WG; Bathgate RA
    Am J Physiol Cell Physiol; 2009 May; 296(5):C1058-66. PubMed ID: 19279230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relaxin family peptide receptor 1 (RXFP1): An emerging player in human health and disease.
    Chen TY; Li X; Hung CH; Bahudhanapati H; Tan J; Kass DJ; Zhang Y
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1194. PubMed ID: 32100955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of interactions at the extracellular loops of the relaxin family peptide receptor 1 (RXFP1).
    Diepenhorst NA; Petrie EJ; Chen CZ; Wang A; Hossain MA; Bathgate RA; Gooley PR
    J Biol Chem; 2014 Dec; 289(50):34938-52. PubMed ID: 25352603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The chemically synthesized human relaxin-2 analog, B-R13/17K H2, is an RXFP1 antagonist.
    Hossain MA; Samuel CS; Binder C; Hewitson TD; Tregear GW; Wade JD; Bathgate RA
    Amino Acids; 2010 Jul; 39(2):409-16. PubMed ID: 20043231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. H3 relaxin demonstrates antifibrotic properties via the RXFP1 receptor.
    Hossain MA; Man BC; Zhao C; Xu Q; Du XJ; Wade JD; Samuel CS
    Biochemistry; 2011 Mar; 50(8):1368-75. PubMed ID: 21229994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relaxin signaling activates peroxisome proliferator-activated receptor gamma.
    Singh S; Bennett RG
    Mol Cell Endocrinol; 2010 Feb; 315(1-2):239-45. PubMed ID: 19712722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RXFP1-inactive relaxin activates human glucocorticoid receptor: further investigations into the relaxin-GR pathway.
    Dschietzig T; Bartsch C; Baumann G; Stangl K
    Regul Pept; 2009 Apr; 154(1-3):77-84. PubMed ID: 19101597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relaxin receptor as a therapeutic target - perspectives from evolution and drug targeting.
    Bathgate RAD; Kocan M; Scott DJ; Hossain MA; Good SV; Yegorov S; Bogerd J; Gooley PR
    Pharmacol Ther; 2018 Jul; 187():114-132. PubMed ID: 29458108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.